CYMAT ENTERS INTO LETTER OF INTENT WITH RIO TINTO ALCAN TO ACQUIRE TECHNOLOGY & ASSUME CUSTOMERS OF THEIR PROPRIETARY ALUMINUM METAL MATRIX COMPOSITES BUSINESS

Rhea-AI Summary

Cymat Technologies (OTCQB: CYMHF) has entered into a Letter of Intent with Rio Tinto Alcan (RTA) to acquire their aluminum metal matrix composites (MMC) technology and customer base. RTA, the world's only major supplier of this proprietary MMC, is exiting the business due to strategic reorganization. The acquisition could generate incremental annual revenue of $7.5M-$10M for Cymat.

The company plans to establish MMC production at its Mississauga plant, leveraging existing workforce and facilities. Capital costs are estimated at $2M-$2.5M, with technology transfer expenses in the low to mid six-figure range. The initiative will be financed through warrant proceeds and equipment financing. The acquisition offers dual benefits: adding substantial uncorrelated revenue and reducing Cymat's primary input material costs significantly.

Positive

• Potential additional annual revenue of $7.5M-$10M with margins comparable to or better than AlusionTM product
• Acquisition reduces cost of primary input materials significantly, improving price competitiveness
• Ability to leverage existing facilities and workforce minimizes operational costs
• Acquisition of established customer base from sole major global supplier
• Synergistic integration with existing operations and skill sets

Negative

• Required capital investment of $2M-$2.5M plus additional technology transfer expenses
• Integration and transition risks in assuming RTA's customer base
• Execution risk in establishing new production capability
• Additional financing needed through warrant proceeds and equipment financing

MISSISSAUGA, ON, June 24, 2025 /PRNewswire/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is pleased to announce that it has entered into a Letter of Intent ("LOI") with Rio Tinto Alcan Inc. ("RTA") to acquire the technology and related knowhow to manufacture its proprietary aluminum metal matrix composites ("MMC") and to facilitate the transfer of RTA's customers for the product.

MMC is a ceramic particle-infused aluminum used in the automotive and rail industries for light weight components requiring extreme wear-resistance. RTA, who has been manufacturing and selling its proprietary MMCs for over 40 years, has decided to exit the business due to a strategic reorganization. As the only major supplier of this proprietary MMC in the world, RTA is seeking a smooth and un-interrupted transition of this business for its long-standing customers. Cymat utilizes this product as its primary input material to produce stabilized aluminum foam ("SAF"). Its familiarity with the material makes Cymat well qualified and uniquely positioned to take on this business line.

Cymat intends to establish MMC production capability within its existing Mississauga plant. Given the similarities and common skill sets required to produce MMC with its own SAF product, Cymat will have the ability to utilize its existing workforce, engineering, and support services to efficiently and economically produce this proprietary MMC.

From a financial perspective, historical sales volumes provided by RTA suggest that Cymat could realize incremental annual revenue in the range of $7.5M - $10M with margins comparable to or better than its Alusion^TM product. Capital costs for equipment are estimated to be in the range of $2M - $2.5M. Technology and knowhow transfer expenses, while yet to be finalized, are anticipated to be in the low to mid six-figure range.  Cymat is planning to finance this initiative through a combination of existing outstanding warrant proceeds and equipment financing sources. Cymat anticipates that it will be fully commissioned and operational with this product line by fiscal year end. 

The assumption of this new business line provides two major benefits for Cymat. Firstly, it adds a substantial uncorrelated and predictable revenue stream to Cymat's existing business. With its ability to utilize existing resources among other synergies, Cymat expects this venture to be highly profitable. Secondly, it reduces the cost of Cymat's primary input material and majority cost element by a substantial factor. This positions Cymat to be extremely price-competitive and compelling for targeted customers in its key automotive vertical. It also opens up business opportunities in high-volume verticals where SAF has historically been price un-competitive.

Michael Liik, Cymat's CEO and Chairman, stated, "This is a highly unique opportunity for Cymat to leverage our existing facilities and unique skill sets to realize a major expansion of our business. This initiative combined with anticipated sales growth in the nuclear and military verticals in our  SAF business should accelerate our path to substantial profitability " He added, "Since inception, we have looked for ways to bring this capability inhouse and have now achieved this feat -together with a substantial book of business - making this absolutely transformational for Cymat."

About Cymat Technologies Ltd.

Cymat Technologies Ltd. has the global rights, through patents and established know-how, to manufacture and sell Stabilized Aluminum Foam ("SAF"), a unique, ultra-light, cellular metallic material. The proprietary production process entails the injection of gases through a molten bath of alloyed aluminum infused with ceramic particles. The result is an advanced, lightweight, recyclable material that exhibits unique characteristics including customizable density and dimensions; mechanical energy absorption; thermal and acoustic insulation; and time, temperature and strain-rate insensitivity. A key benefit of this continuous foam production process is its scalability and resultant low cost of production. SAF is used in such industries as architectural design, military and automotive. Cymat markets its architectural SAF under the Alusion^TM brand and its automotive and military SAF under the SmartMetal^TM brand. For further information, please visit our website at www.cymat.com.

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Certain material assumptions regarding such forward-looking statements may be discussed in this news release and the Company's annual and quarterly management's discussion and analysis filed at www.sedar.com. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cymat-enters-into-letter-of-intent-with-rio-tinto-alcan-to-acquire-technology--assume-customers-of-their-proprietary-aluminum-metal-matrix-composites-business-302489640.html

SOURCE Cymat Technologies Ltd.

FAQ

What is the expected revenue impact of CYMHF's acquisition of Rio Tinto Alcan's MMC business?

The acquisition is expected to generate incremental annual revenue of $7.5M-$10M with margins comparable to or better than Cymat's AlusionTM product.

How much will CYMHF's acquisition of RTA's MMC technology cost?

The acquisition requires $2M-$2.5M in capital costs for equipment, plus technology transfer expenses in the low to mid six-figure range.

When will CYMHF's new MMC production line be operational?

Cymat anticipates the MMC production line to be fully commissioned and operational by fiscal year end.

How will CYMHF finance the acquisition of RTA's MMC technology?

The acquisition will be financed through a combination of existing outstanding warrant proceeds and equipment financing sources.

What are the main benefits of CYMHF's acquisition of RTA's MMC business?

The acquisition provides two major benefits: 1) Adding substantial uncorrelated revenue stream, and 2) Reducing the cost of Cymat's primary input material significantly, improving price competitiveness.